XGN · Exagen Inc.

$4.67 -0.29 (-5.76%) At close · Jul 24

Market Cap

$113.07M

24.16M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Aballi	CEO	$540,000	—	$402,750	$203,018	$237,600	$17,500	$1,400,868
Jeffrey Black	CFO	$465,000	—	$53,700	$27,069	$186,000	$14,421	$746,190

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Aballi	CEO	$525,000	—	$353,500	—	$288,750	$17,250	$1,184,500
Jeffrey Black	CFO	$141,536	$125,000	$670,500	—	$84,000	—	$1,021,036
Kamal Adawi	CFO	$253,684	—	$151,500	—	—	$385,106	$790,290

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark Hazeltine	Chief Business Officer	$378,416	—	$239,000	—	—	$436,578	$1,053,994
John Aballi	CEO	$525,000	$76,125	—	—	$317,625	$13,200	$931,950
Kamal Adawi	CFO	$406,477	$35,083	$239,000	—	$221,327	$13,200	$915,087
Jeffrey Black	CFO	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Fortunato Ron Rocca	CEO	$447,218	—	$657,750	—	—	$437,075	$1,542,043
Kamal Adawi	CFO	$398,507	$72,573	$556,895	—	—	$12,200	$1,040,175
Mark Hazeltine	Chief Business Officer	$398,507	$72,573	$556,895	—	—	$12,200	$1,040,175
Debra Zack	Chief Medical Officer	$373,685	—	$438,500	—	—	$213,771	$1,025,956
John Aballi	CEO	$111,056	$22,330	$850,500	—	—	—	$983,886

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Fortunato Ron Rocca	CEO	$594,707	—	$910,000	$388,596	$537,625	$8,700	$2,439,628
Debra Zack	Chief Medical Officer	$415,523	—	$682,500	$121,436	$202,550	$8,550	$1,430,559
Kamal Adawi	CFO	$406,367	—	$682,500	$121,436	$194,554	$8,700	$1,413,557
Mark Hazeltine	Chief Business Officer	$390,563	—	$682,500	$121,436	$194,554	$8,700	$1,397,753
John Aballi	CEO	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Fortunato Ron Rocca	CEO	$499,733	—	—	$1,742,603	$566,799	$8,550	$2,817,685
Kamal Adawi	CFO	$381,170	—	—	$590,237	$230,580	$8,550	$1,210,537
Debra Zack	Chief Medical Officer	$296,692	—	—	$633,440	$185,617	$6,533	$1,122,282

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Fortunato Ron Rocca	CEO	$358,195	$73,875	—	$1,082,039	$105,216	$8,400	$1,627,725
Kamal Adawi	CFO	$278,110	$28,679	—	$168,831	$40,846	$8,400	$524,866
Thierry Dervieux	Chief Scientific Officer	$268,827	$27,678	—	$84,989	$39,420	$46,052	$466,966

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Fortunato Ron Rocca	CEO	$348,113	$157,357	—	$53,499	—	$8,250	$567,219
Thierry Dervieux	Chief Scientific Officer	$278,391	$62,920	—	$16,050	—	$8,250	$365,611
Kamal Adawi	CFO	$271,039	$61,088	—	$13,910	—	$8,250	$354,287

Key facts CIK 1274737 CUSIP 30068X103 13F (30d) 1 filings 1 filers Visit website Investor relations